Dr. Peter D. Cole, MD
- Publications
- 78
- Clinical trials
- 10
- MIPS score, 2024
- 88
- Industry payments
- $1,063
- Affiliated sites
- 1
- Practice address
- 579 Cranbury Rd, East Brunswick, NJ 08816
- Practice phone
- Call (732) 253-4404
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Contemporary Plastic Surgi Center, LLC
East Brunswick, New Jersey
Find Dr. Cole's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Peter D. Cole is a pediatric hematology and oncology physician in East Brunswick, New Jersey
Dr. Cole practices at Contemporary Plastic Surgi Center, LLC in East Brunswick, New Jersey.
Dr. Cole's NPI, 1376553057, was assigned on August 8, 2006. Dr. Cole graduated from JS Weill Medical College, Cornell University in 1993. Dr. Cole holds New Jersey license 25MA069144.
- NPI
- 1376553057NPI Registry (opens in a new tab)
- NPI enumeration date
- August 8, 2006
- NPI status
- Active
- Practice phone
- (732) 253-4404
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Peter D. Cole practices at Contemporary Plastic Surgi Center, LLC in East Brunswick, New Jersey
Dr. Cole's primary practice is Contemporary Plastic Surgi Center, LLC, at 579 Cranbury Rd, East Brunswick, NJ 08816 in Middlesex County. The practice phone is (732) 253-4404.
- Contemporary Plastic Surgi Center, LLC579 Cranbury Rd, East Brunswick, NJ 08816 · Middlesex CountyPhone(732) 253-4404
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Peter D. Cole is affiliated with 2 sites of care and 1 medical group
Dr. Cole's primary practice is Contemporary Plastic Surgi Center, LLC in East Brunswick, New Jersey. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Cole to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Peter D. Cole's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Contemporary Plastic Surgi Center, LLC | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Peter D. Cole is one of 69 pediatric hematologys and oncology physicians in New Jersey
Pediatric hematology-oncology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Cole is licensed in New Jersey.
Specialties and state licenses
- Pediatric hematology and oncology, New JerseyPrimary
Pediatric hematologys and oncology physicians near Dr. Cole
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Peter D. Cole's patients have a median age of 14
Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 14, with 29% women.
Dr. Cole's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 14
Patient panel by sex, all payers
- Women29%
- Men71%
Source: Dmand AI Patient Panel Data
Dr. Peter D. Cole scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cole for performance year 2024, reported as part of a group.
Dr. Cole's MIPS scores, performance year 2024
- 88of 100Final score
- 70.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
Dr. Peter D. Cole has 78 publications on record
Dmand AI links 78 papers to Dr. Cole, published from 2010 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols and Hodgkin Disease. Dr. Cole has published most often in Pediatr Blood Cancer. Dr. Cole's most frequent co-authors are Kara Maureen Kelly, MD, Lewis B. Silverman, MD and Luis Antonio Clavell, MD.
Dr. Cole's papers by year, 2016 to 2025
Topics Dr. Cole writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Hodgkin Disease
- Methotrexate
- Brentuximab Vedotin
- Black or African American
- Cancer Survivors
- Healthcare Disparities
Dr. Cole's most frequent co-authors
- Kara Maureen Kelly, MD31 shared papers
- Lewis B. Silverman, MD21 shared papers
- Luis Antonio Clavell, MD17 shared papers
Recent publications by Dr. Cole
JAMA Netw Open
Pediatr Blood Cancer
Pediatr Blood Cancer
See who Dr. Cole researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cole works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Peter D. Cole has worked on 10 clinical trials
Dmand AI links Dr. Cole to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Burkitt Lymphoma, Ganglioneuroblastoma and Epstein-Barr Virus Infections. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Cole by phase
- NonePhase 1: no trials
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Cole's trials
- Burkitt Lymphoma
- Ganglioneuroblastoma
- Epstein-Barr Virus Infections
- Neuroblastoma
- Chondrosarcoma, Mesenchymal
Investigators on the most trials with Dr. Cole
- Guy Howard Grayson, MD, PA8 shared trials
- Birte Wistinghausen, MD8 shared trials
- Wendy L. Woods-Swafford, MD8 shared trials
Recent clinical trials with Dr. Cole
Matched Targeted Therapy (MTT) Recommendation for Patients With Recurrent, Refractory, or High Risk Leukemias and Myelodysplastic Syndrome (opens in a new tab)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (opens in a new tab)
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (opens in a new tab)
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma (opens in a new tab)
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Peter D. Cole received $1,063 in industry payments from 2016 to 2025
CMS Open Payments shows 17 general payments to Dr. Cole from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Merck Sharp & Dohme Corporation paid the most, $500.
General payments to Dr. Cole by program year, 2016 to 2025
General payments to Dr. Cole by kind, 2016 to 2025
- Food and beverage$80376%
- Travel and lodging$26024%
Companies that paid Dr. Cole the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Peter D. Cole graduated from JS Weill Medical College, Cornell University
Dr. Cole graduated from JS Weill Medical College, Cornell University in 1993.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Peter D. Cole's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Peter D. Cole
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Peter D. Cole's NPI number?
Dr. Peter D. Cole's NPI number is 1376553057. It was assigned on August 8, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Peter D. Cole?
Dr. Peter D. Cole is a pediatric hematology and oncology physician in East Brunswick, New Jersey. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Peter D. Cole practice?
Dr. Cole practices at 579 Cranbury Rd, East Brunswick, NJ 08816. Dr. Cole's primary practice is Contemporary Plastic Surgi Center, LLC in East Brunswick, New Jersey. Dmand AI also links Dr. Cole to 1 group practice or clinic.
What is Dr. Peter D. Cole's office phone number?
The practice phone on file for Dr. Cole is (732) 253-4404.
What is Dr. Peter D. Cole's medical license number?
Dr. Cole holds New Jersey license 25MA069144.
What medical group is Dr. Peter D. Cole part of?
Dr. Cole is linked to Rutgers-RWJ Scleroderma Program.
What is Dr. Peter D. Cole's MIPS score?
Dr. Cole's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
Where did Dr. Peter D. Cole go to medical school?
Dr. Cole graduated from JS Weill Medical College, Cornell University in 1993.
Has Dr. Peter D. Cole received payments from drug or device companies?
CMS Open Payments shows $1,063 in general payments to Dr. Cole from 8 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Peter D. Cole been practicing?
Dr. Cole graduated from medical school in 1993, 33 years ago.
Does Dr. Peter D. Cole do research?
Dmand AI links 78 publications to Dr. Cole, published from 2010 to 2025. Dr. Cole has worked on 10 clinical trials.
Who does Dr. Peter D. Cole publish with?
Dr. Cole's most frequent co-authors are Kara Maureen Kelly, MD (31 shared papers), Lewis B. Silverman, MD (21 shared papers) and Luis Antonio Clavell, MD (17 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card